ADAR1 Capital Management Reports Acquisition of $5.28 in InMed Pharmaceuticals Common Shares

PUBT · 2d ago
ADAR1 Capital Management Reports Acquisition of $5.28 in InMed Pharmaceuticals Common Shares
  • ADAR1 Capital Management reported purchasing 4 InMed Pharmaceuticals common shares at $1.32 each.
  • Indirect beneficial ownership totaled 956,584 common shares following the purchase.
  • Joint filers ADAR1 Capital Management and its manager, Daniel Schneeberger, were identified as 10% owners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000028), on October 27, 2026, and is solely responsible for the information contained therein.